1,218
Views
5
CrossRef citations to date
0
Altmetric
Original Article: Clinical

A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue

, , , , , , , , , , , & show all
Pages 594-601 | Received 05 Jul 2013, Accepted 31 Mar 2014, Published online: 19 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nicolas Kint, Sophie Vlayen & Michel Delforge. (2019) The treatment of multiple myeloma in an era of precision medicine. Expert Review of Precision Medicine and Drug Development 4:3, pages 153-162.
Read now

Articles from other publishers (4)

Francesca Gay, Giuseppe Bertuglia & Roberto Mina. (2023) A rational approach to functional high-risk myeloma. Hematology 2023:1, pages 433-442.
Crossref
Sahar Hadi Pour, Shamsuddin Shahid & Saad Sh. Sammen. 2023. Handbook of Hydroinformatics. Handbook of Hydroinformatics 353 377 .
Raphael Szalat, Herve Avet-Loiseau & Nikhil C. Munshi. (2016) Gene Expression Profiles in Myeloma: Ready for the Real World?. Clinical Cancer Research 22:22, pages 5434-5442.
Crossref
C Gu, Y Yang, R Sompallae, H Xu, V S Tompkins, C Holman, D Hose, H Goldschmidt, G Tricot, F Zhan & S Janz. (2015) FOXM1 is a therapeutic target for high-risk multiple myeloma. Leukemia 30:4, pages 873-882.
Crossref